Latest Entry: American Pravda and New York's Sixth Crime Family     Latest Comments: Talk Back Here

« The Australian: Drones Pick Off 'Rats' of Falluja | Main | Lessons Of That Bin Laden Tape »

November 16, 2004

Inhibitory Effect of Antituberculosis Drugs on Human Cytochrome P450-Mediated Activities.

Topics: Clinical Pharmacology

Abstract Report in J Pharmacol Sci. 2004 Nov 5 [Epub ahead of print]. Nishimura Y, Kurata N, Sakurai E, Yasuhara H., Department of Pharmacology, School of Medicine, Showa University:

The potential for drug-drug interactions mediated by the inhibition of cytochrome P-450 (CYP) were concerned during antituberculosis therapy. However, the information regarding human CYP inhibition by antituberculosis drugs is limited to isoniazid. In the current study, we examined the inhibitory effects of pyrazinamide and ethionamide, both of which are chemically related to isoniazid, on the CYP-mediated activities in human liver microsomes (HLM) and compared them to that of isoniazid. No remarkable effects on any CYP activities were observed by pyrazinamide and ethionamide. In contrast, in addition to the reported inhibitory effect of isoniazid on CYP1A2, CYP2A6, CYP2C19, and CYP3A activities, our results newly showed its effect on CYP2C9 and CYP2E1 activities. Isoniazid showed potent direct inhibitory effect on S-warfarin 7-hydroxylation while a preincubation step in the presence of NADPH was needed to inhibit chlorzoxazone 6-hydroxylation.

Furthermore, irreversible inhibition of CYP2C19 activity by isoniazid was also observed in the dilution study. These results suggested that pyrazinamide and ethionamide did not seem to cause drug interactions mediated by the inhibition of CYP. In contrast, isoniazid might contribute to the severe drug interactions by a different inhibitory mechanism depending on each of the CYP isozymes, in addition to the reported observations.

Posted by Hyscience at November 16, 2004 9:50 PM



Articles Related to Clinical Pharmacology: